Phytotoxicity Evaluation of Five Proton-Pump Inhibitors Through Plant-Based Eukaryotic Test Models-Reference-Cited by-同舟云学术

Phytotoxicity Evaluation of Five Proton-Pump Inhibitors Through Plant-Based Eukaryotic Test Models

Published:2023-08-12 Issue: Volume: Page:
ISSN:0369-8211
Container-title:Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
language:en
Short-container-title:Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci.

Author:

Islam Muhammad Torequl,Iriti Marcello,Martorell Miquel,Sharifi-Rad Javad^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s40011-023-01508-w.pdf

Reference30 articles.

1. Hálfdánarson ÓÖ, Pottegård A, Björnsson ES, Lund SH, Ogmundsdottir MH, Steingrímsson E, Ogmundsdottir HM, Zoega H (2018) Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol 11:1756284818777943. https://doi.org/10.1177/1756284818777943

2. Scheiman JM (2013) The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthr Res Ther 15(Suppl 3):S5. https://doi.org/10.1186/ar4177

3. McCarthy DM (2010) Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 26(6):624–631. https://doi.org/10.1097/MOG.0b013e32833ea9d9

4. Rossi S (2006) Australian medicines handbook. Sydney. https://www.scirp.org/(S(i43dyn45teexjx455qlt3d2q))/reference/ReferencesPapers.aspx?ReferenceID=59446

5. Clark DW, Strandell J (2006) Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Eur J Clin Pharmacol 62(6):473–479. https://doi.org/10.1007/s00228-006-0131-1